Hot flashes, night sweats, and broken sleep can persist through perimenopause and after menopause even when you have already adjusted caffeine, alcohol, exercise, and bedtime routines. When patients decide to look at hormone therapy (HRT), one of the first questions I hear is: "Why do I need progesterone if it is the estrogen that helps my symptoms?"
In my practice at Tall Tree Cordova Bay and James Bay, systemic HRT usually means body-identical estradiol, as a patch or gel, paired with oral micronized progesterone for patients who still have a uterus. The estrogen does most of the symptom work. The progesterone keeps the uterine lining healthy while you take it. Used together and reviewed over time, the pairing is a well-studied, thoughtful option for the right patient.
So why are they paired, exactly?
Estrogen tells the lining of the uterus (the endometrium) to grow. Before menopause, your own progesterone rises after ovulation each month and signals that lining to mature and shed. After menopause, that progesterone signal is gone.
If estrogen is given on its own to someone with a uterus, the lining can keep thickening. Over time that can lead to endometrial hyperplasia (overgrowth of the lining), and estrogen-only therapy raises the risk of endometrial cancer. Adding a progestogen protects the lining. That is why every major menopause guideline, including The Menopause Society, NICE in the UK, and Canada's SOGC, recommends a progestogen with systemic estrogen for patients who have a uterus.
If you have had a hysterectomy, you do not need progesterone for this purpose, and estrogen alone is usually the plan.
What "body-identical" means here
Estradiol is the same molecule your ovaries made before menopause. Micronized progesterone is the same molecule as the progesterone your body made after ovulation.
Older HRT research mostly used different hormones: conjugated estrogens taken by mouth, paired with synthetic progestins like medroxyprogesterone acetate. That matters when you read headlines, because the type of estrogen, the type of progestogen, and the route all change the risk picture.
How the schedule works
There are two common ways to take progesterone with estrogen. Your prescriber chooses with you based on where you are in the transition:
- Continuous (daily): progesterone is taken every day along with estrogen. In my practice this is my usual approach. For patients who are still having periods in perimenopause, I typically have them pause the progesterone during their menstrual bleed and restart it afterward. Once periods have stopped, most patients take it daily with little or no bleeding.
- Cyclic (sequential): progesterone is taken for only part of each month, usually followed by a planned, period-like bleed. This is another option some prescribers use for patients still in perimenopause or recently past their last period.
Many patients take oral micronized progesterone at bedtime. Beyond protecting the uterine lining, progesterone can be helpful for sleep and mood, and some patients find the bedtime dosing helps them rest. It can also make some people drowsy.
A hormonal IUD is another way to protect the lining. Instead of oral micronized progesterone, a progestin-based intrauterine system (IUD) can deliver the progestogen directly to the uterus and serve the same protective role. If that appeals to you, it is worth raising at your consult.
About bleeding: spotting or irregular bleeding is common in the first few months of HRT, or after a change in dose or product. NICE guidance advises seeking care promptly if unscheduled bleeding continues beyond the first six months, or starts after it had settled. Any new bleeding after menopause is worth getting checked.
What the research actually shows
For the uterine lining: In the PEPI trial, a three-year randomized study of 596 postmenopausal women, more than one in five women taking estrogen alone developed complex hyperplasia of the lining. Women taking estrogen with a progestogen, including a group taking cyclic micronized progesterone, had rates similar to placebo. A Cochrane review of the wider evidence came to the same conclusion: adding a progestogen protects the endometrium.
For blood clots: A large UK study of more than 80,000 women with blood clots, compared with nearly 400,000 matched women without, found that estrogen taken through the skin (patch or gel) was not linked to a higher risk of blood clots, across different regimens. Oral estrogen was linked to a higher risk. This is one reason I often lean toward a patch or gel.
For the breast: In a French cohort of more than 80,000 postmenopausal women, estrogen paired with micronized progesterone was not linked to a higher breast cancer risk over an average of about eight years, while estrogen paired with other synthetic progestins was. An international expert review later concluded that estrogen with oral micronized progesterone does not increase breast cancer risk for up to five years of use.
For the bigger picture: The Menopause Society's 2022 position statement concludes that HRT remains the most effective treatment for hot flashes and night sweats, and that for patients under 60 or within 10 years of menopause without contraindications, the benefit-risk balance is favourable for bothersome symptoms and for preventing bone loss.
Is this a fit for you?
It may be a good conversation when:
- Hot flashes, night sweats, or sleep disruption persist and are affecting your days
- You have a uterus and are considering systemic estrogen
- You are already on estrogen and want to understand or review your progesterone plan
- You are in perimenopause with changing cycles and want to know how progesterone fits around your cycle
A consult decides whether it is right for you. Some situations need extra care or a different plan:
- Unexplained bleeding after menopause needs to be assessed before starting HRT
- A personal history of breast cancer or another hormone-sensitive cancer: this decision belongs with your oncology team. Post-cancer menopause care is outside my practice
- A history of blood clots, stroke, heart disease, or liver disease needs a careful individual review, and HRT may not be the right choice
What happens at the visit
Menopause consult (booked as a Naturopathic Consultation): we go through your symptoms, cycle and menopause history, personal and family history, current medications, and any recent bloodwork. We talk about whether systemic HRT makes sense, whether estrogen should come as a patch or gel, and how to take progesterone, daily or paused during bleeding, based on where you are in the transition. If HRT is a good fit, I prescribe it at that visit and walk you through how to take it.
Follow-up: we check how your symptoms are responding, how your sleep and bleeding pattern are settling, and adjust the plan together. From there we review the benefits and risks of continuing at regular visits.
Common questions
I had a hysterectomy. Do I still need progesterone? Usually not. The main reason progesterone is paired with estrogen is to protect the uterine lining, so without a uterus, estrogen alone is typically the plan. There are a few situations where a progestogen is still considered, such as a history of endometriosis, so it is worth going through your surgical history at the consult.
Is micronized progesterone the same as the progestin in the birth control pill? No. Micronized progesterone is the same molecule your body makes. Most birth control pills and much of the older HRT research used synthetic progestins, which act on the body in different ways. That difference is part of why newer research on body-identical progesterone looks more reassuring for the breast and for blood clots.
Does progesterone raise breast cancer risk? This is an important question, and the honest answer has a few layers. Studies so far suggest estrogen paired with micronized progesterone carries a lower breast risk than estrogen paired with older synthetic progestins, and an expert review found no increase for up to about five years of use. Beyond five years, there is limited evidence of a small increase, and NICE notes there is still not enough evidence to say for certain how different progestogens compare. So we go through your own breast history and risk factors, and we revisit the plan over time.
Will I bleed on HRT? It depends on where you are in the transition and the schedule. If you are still having periods in perimenopause, you will keep having menstrual bleeding, and I typically pause progesterone during it. With cyclic progesterone, a planned monthly bleed is expected. With daily progesterone after periods have stopped, spotting is common in the first few months, and most patients settle to little or no bleeding. Bleeding that continues beyond the first six months, or starts again after it had stopped, should be checked.
Can I just use estrogen and skip the progesterone if it bothers me? If you have a uterus, using systemic estrogen without a progestogen is not recommended, because of the risk to the lining. If progesterone side effects bother you, such as drowsiness, bloating, or mood changes, that is worth raising. There are often adjustments we can make to the timing, the schedule, or the type of progestogen.
If hot flashes, night sweats, or sleep disruption are getting in the way of your life and you are in British Columbia, you are welcome to book a consult. We can sit down together and map whether estradiol and progesterone, another form of HRT, or a non-hormonal approach is a good fit for you.
If vaginal dryness or bladder symptoms are also part of the picture, my post on vaginal estrogen in menopause covers that side of care.
Perimenopause and menopause care (HRT) · Free HRT guide · Book at Tall Tree Cordova Bay · Book at Tall Tree James Bay
A precision practice.
Sources
- "The 2022 Hormone Therapy Position Statement of The North American Menopause Society" Advisory Panel. Menopause. 2022;29(7):767–794. https://doi.org/10.1097/GME.0000000000002028
- National Institute for Health and Care Excellence (NICE). Menopause: identification and management (NG23). Updated 2024. https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
- Yuksel N, et al. Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle. J Obstet Gynaecol Can. 2021;43(10):1188–1204. https://doi.org/10.1016/j.jogc.2021.08.003
- The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. JAMA. 1996;275(5):370–375. https://doi.org/10.1001/jama.1996.03530290040035
- Furness S, et al. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev. 2012;(8):CD000402. https://doi.org/10.1002/14651858.CD000402.pub4
- Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. https://doi.org/10.1136/bmj.k4810
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103–111. https://doi.org/10.1007/s10549-007-9523-x
- Stute P, Wildt L, Neulen J. The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric. 2018;21(2):111–122. https://doi.org/10.1080/13697137.2017.1421925
Disclaimer
This content is general educational information, not medical advice, and not a substitute for individualized care from your own qualified provider. Dr. Sydney Green, ND provides clinical care only to patients within British Columbia.